Mobile Menu - OpenMobile Menu - Closed

Congressman Krishnamoorthi Condemns Trump Administration Proposal To Strip FDA Of Power To Regulate Tobacco Industry

February 12, 2020
Press Release
The Trump budget plan would transfer the FDA’s tobacco oversight powers to a new agency with a director appointed directly by the president

WASHINGTON, D.C. – Today, Congressman Raja Krishnamoorthi responded to President Donald Trump’s recent budget proposal that shifts the oversight of tobacco products from the Food and Drug Administration (FDA) to its own independent agency run by a Trump-picked director. In 2009, the Tobacco Control Act established the Center for Tobacco Products within the FDA, and gave it the authority to regulate tobacco products.

“As our country combats the youth vaping epidemic, we can’t afford to risk weakening public health efforts through stripping the FDA of its authority to regulate tobacco and e-cigarette products,” said Congressman Krishnamoorthi. “For more than a decade, the FDA’s Center for Tobacco Products has developed the resources and expertise necessary to regulate the tobacco industry and protect the public. While I have not agreed with every decision by the Trump FDA, especially on the issue of e-cigarettes, it would be a mistake to strip the agency of one of its core regulatory responsibilities and to shift it to an entirely new and potentially politicized entity. As the Chairman of the House Oversight Subcommittee on Economic and Consumer Policy, I am dedicated to ensuring the federal government is serious in its response to the youth vaping epidemic, and this proposal fails that test.”